Cholinergic System Changes in Dopa-Unresponsive Freezing of Gait in Parkinson's Disease
- PMID: 40219650
- PMCID: PMC12353882
- DOI: 10.1002/mds.30196
Cholinergic System Changes in Dopa-Unresponsive Freezing of Gait in Parkinson's Disease
Abstract
Background: Freezing of gait (FoG) is a debilitating mobility disturbance that becomes increasingly resistant to dopaminergic pharmacotherapies with advancing Parkinson's disease (PD). The pathophysiology underlying the response of FoG to dopaminergic treatment is poorly understood. Prior vesicular acetylcholine transporter positron emission tomography (VAChT PET) imaging studies implicate the degeneration of cholinergic pathways, including bilateral striatal and limbic archicortex deficits, as significant contributors to FoG.
Objective: We aim to investigate whether specific cholinergic system changes are associated with FoG responsiveness to levodopa treatment in PD patients.
Methods: Thirty six PD subjects (31M/5F) completed [18F]-fluoroethoxybenzovesamicol ([18F]FEOBV) vesicular acetylcholine transporter positron emission tomography (VAChT PET) and underwent videotaped clinical assessments for FoG on and off levodopa.
Results: Sixteen subjects had l-dopa-unresponsive FoG. Whole brain voxel-based analyses of [18F]FEOBV PET (false discovery rate-corrected at P < 0.05 and adjusted for levodopa-equivalent dose) showed that those with l-dopa-unresponsive FoG had more severe cholinergic terminal deficits in the bilateral insula, hippocampi, fimbria, and lateral geniculate nuclei; left mid-temporal, putamen, and posterior cingulate regions; and the right mid-frontal region and anterior ventral nucleus of the thalamus compared to those with l-dopa-responsive FoG.
Conclusion: FoG unresponsive to levodopa is associated with bilateral cholinergic terminal reductions, mostly in extra-striatal regions involved in multisensory and cognitive integration of gait and postural control as well as spatial navigation. The lack of specific striatal involvement points to the disruption of widespread cerebral network functions underlying l-dopa-unresponsive FoG in PD and may explain the treatment-resistant nature of FoG to levodopa. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Keywords: Parkinson's disease; acetylcholine; freezing of gait; levodopa responsiveness; positron emission tomography (PET).
© 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Figures
References
-
- Forsaa EB, Larsen JP, Wentzel‐Larsen T, Alves G. A 12‐year population‐based study of freezing of gait in Parkinson's disease. Parkinsonism Relat Disord 2015;21:254–258. - PubMed
-
- López IC, Ruiz PJG, del Pozo SVF, Bernardos VS. Motor complications in Parkinson's disease: ten year follow‐up study. Mov Disord 2010;25:2735–2739. - PubMed
-
- Kerr GK, Worringham CJ, Cole MH, Lacherez PF, Wood JM, Silburn PA. Predictors of future falls in Parkinson disease. Neurology 2010;75:116–124. - PubMed
-
- Perez‐Lloret S, Negre‐Pages L, Damier P, et al. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease. JAMA Neurol 2014;71:884–890. - PubMed
-
- Nonnekes J, Snijders AH, Nutt JG, Deuschl G, Giladi N, Bloem BR. Freezing of gait: a practical approach to management. Lancet Neurol 2015;14:768–778. - PubMed
MeSH terms
Substances
Grants and funding
- Michael J. Fox Foundation for Parkinson's Research
- R01 NS070856/NS/NINDS NIH HHS/United States
- P50 NS091856/NH/NIH HHS/United States
- P50 NS123067/NS/NINDS NIH HHS/United States
- I01 RX001631/RX/RRD VA/United States
- I01 RX003397/RX/RRD VA/United States
- R01 AG073100/AG/NIA NIH HHS/United States
- P01 NS015655/NH/NIH HHS/United States
- P01 NS015655/NS/NINDS NIH HHS/United States
- P50 NS123067/NH/NIH HHS/United States
- RO1 NS070856/NH/NIH HHS/United States
- P50 NS091856/NS/NINDS NIH HHS/United States
- P01 NS015655/NH/NIH HHS/United States
- P50 NS091856/NH/NIH HHS/United States
- P50 NS123067/NH/NIH HHS/United States
- RO1 NS070856/NH/NIH HHS/United States
- I01 RX001631/RX/RRD VA/United States
LinkOut - more resources
Full Text Sources
Medical
